PRTFDC1 anticorps (N-Term)
Aperçu rapide pour PRTFDC1 anticorps (N-Term) (ABIN631292)
Antigène
Voir toutes PRTFDC1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- PRTFDC1 antibody was raised against the N terminal of PRTFDC1
-
Purification
- Affinity purified
-
Immunogène
- PRTFDC1 antibody was raised using the N terminal of PRTFDC1 corresponding to a region with amino acids AGSSEEAPDYGRGVVIMDDWPGYDLNLFTYPQHYYGDLEYVLIPHGIIVD
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PRTFDC1 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this PRTFDC1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PRTFDC1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PRTFDC1 (phosphoribosyl Transferase Domain Containing 1 (PRTFDC1))
-
Autre désignation
- PRTFDC1
-
Sujet
- PRTFDC1 belongs to the purine/pyrimidine phosphoribosyltransferase family. Epigenetic silencing of PRTFDC1 by hypermethylation of the CpG islands leads to a loss of PRTFDC1 function, which might be involved in squamous cell oral carcinogenesis.
-
Poids moléculaire
- 26 kDa (MW of target protein)
-
Pathways
- Ribonucleoside Biosynthetic Process
Antigène
-